For Malavika Kaur Makol's latest contributions to The Japan Times, see below:
It’s a vast project that shows how governments are growing increasingly concerned about China’s stranglehold over drug supplies — as well as the challenges they face in loosening it.
Even as boosters are likely to keep demand alive for COVID-19 inoculations worldwide, the desperate shortages that existed for much of last year have waned.
Experts are concerned about complacency setting in as people resume social and business activity in the face of waning infections.
